NOVAVAX COVID-19 VACCINE SUBMITTED FOR REGULATORY APPROVAL TO HEALTH CANADA
A new COVID-19 vaccine may be coming to Canada. The Novavax COVID-19 vaccine has recently been submitted for approval by Health Canada and it’s 89-90% effective. Unlike the Pfizer and Moderna Covid-19 vaccines (which are mRNA-based and considered a newly developed technology), the Novavax COVID-19 vaccine is a recombinant protein-based vaccine. This type of vaccine has been used to protect against other common viruses such as Hepatitis B, HPV, Shingles, Whooping Cough, and more.
Please click here for the Global News media link.